Legislation in this area focuses on two issues, access to clinical trials for all patients, and clinical research enhancement. Many people are unable to participate in clinical trials because the associated costs, such as laboratory work, radiology charges, and hospital stays are not paid by their individual or group plan, nor are they covered by Medicare.
All measures are pending.
H.R. 299 - The Public Health Service Act, Amendment. The bill was referred to the House Committee on Commerce. This measure replaces H.R. 4135 which was introduced in the 105th Congress. This measure would amend the Internal Revenue Code to provide for a medical innovation tax credit for clinical testing research expenses attributable to academic medical centers and other qualified hospital research organizations. It is significantly more expensive for companies to perform clinical trials at teaching hospitals than at commercial research organizations.